Literature DB >> 769962

Phase II study of adriamycin (NSC-123127) in patients with metastatic melanoma.

W J Sieper, M J Mastrangelo, R E Belle.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 769962

Source DB:  PubMed          Journal:  Cancer Chemother Rep        ISSN: 0069-0112


× No keyword cloud information.
  3 in total

Review 1.  Chemotherapy of malignant melanoma.

Authors:  R S Benjamin
Journal:  World J Surg       Date:  1979-07-30       Impact factor: 3.352

2.  A phase II, open label, monotherapy study of liposomal doxorubicin in patients with metastatic malignant melanoma.

Authors:  Michael G Smylie; Ralph Wong; Catalin Mihalcioiu; Chris Lee; Jean-Francois Pouliot
Journal:  Invest New Drugs       Date:  2006-09-07       Impact factor: 3.850

3.  Colony growth and clonogenic cell survival in human melanoma xenografts treated with chemotherapy.

Authors:  P J Selby; V D Courtenay; T J McElwain; M J Peckham; G G Steel
Journal:  Br J Cancer       Date:  1980-09       Impact factor: 7.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.